温胆汤治疗缺血性中风病风痰火亢证30例

Wendan Decoction in the Treatment of Ischemic Apoplexy of Wind-phlegm Fire Hyperactivity Syndrome for 30 Cases

目的观察温胆汤加减方治疗缺血性中风病风痰火亢证的临床观察效果。方法选用我院2017年12月—2018年6月收治的60例缺血性中风病风痰火亢证患者,随机分为2组,各30例。观察组采用温胆汤加减方及西医常规脑梗死治疗,对照组仅采用西医常规脑梗死治疗。所有患者经过治疗前后均采用中风病中医症状积分评价疗效,观察治疗前后中医症状积分的改变和证候变化。结果相较对照组,观察组中医证候积分明显减少,差异有统计学意义(P<0.05)。结论温胆汤加减方治疗缺血性中风病风痰火亢证的疗效理想,对患者的主要症状及次要症状均有明显的改善,无不良反应,为缺血性中风病患者提供了新的治疗方案。

Objective To observe the clinical effect of modified Wendan decoction in the treatment of ischemic apoplexy of wind-phlegm fire hyperactivity syndrome. Methods 60 patients with apoplexy in our hospital from December 2017 to June 2018 were selected as the objects of this study. The patients were divided into observation group and control group, with 30 cases in each group. The control group was treated with conventional therapy, while the observation group was treated with Wendan decoction and conventional therapy. TCM symptoms were used to estimate clinical effect. Before and after treatment, TCM symptoms were observed. Result Compared with control group, it is shown that TCM score in observation group was lower, and there had statistical significance. Conclusion Wendan decoction in the treatment of ischemic apoplexy of wind-phlegm fire hyperactivity syndrome has ideal effect, which can obviously improve apoplexy clinical TCM syndrome, has no adverse reaction, and provide a new treatment for patients with ischemic apoplexy.